Risk of progression in intermediate age-related macular degeneration among patients using systemic beta-blockers.

Front Ophthalmol (Lausanne) · 2025 · PMC12034660 · PMID 40297766

Europe PMC DOI

hedged sentence

0.0360

closest p · 0.7× alpha

0.0360

boldest claim

The sentences

modestly significantp = 0.036actually significant

Univariate Cox proportional hazard modeling revealed a modestly significant difference in HR for conversion to NV AMD among beta-blocker users (HR: 1.92 [95% CI: 1.04, 3.55], p = 0.036) but no significant difference for conversion to any advanced AMD or advanced NNV ( Table 3 ).

also in 43 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.